Researchers Identify Protein Target to Enhance Glioblastoma Treatment Efficacy

Ohio State University researchers have identified the SET protein as a potential target to improve glioblastoma treatment. Blocking SET in preclinical experiments made tumors more susceptible to radiation and chemotherapy by restoring PP2A enzyme activity. This discovery aims to enhance current therapies, though human testing is necessary to confirm safety and efficacy.